Jove
Visualize
Contact Us

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Retroviruses02:33

Retroviruses

12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
Viral Mutations00:36

Viral Mutations

32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. The Hepatocyte Traffic Network In The Human Hepatitis A Virus Biological Cycle From An Evolutionary Perspective.
  1. Home
  2. The Hepatocyte Traffic Network In The Human Hepatitis A Virus Biological Cycle From An Evolutionary Perspective.

Related Experiment Video

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

The hepatocyte traffic network in the human hepatitis A virus biological cycle from an evolutionary perspective.

Albert Carcereny1, Alba Arrebola1, Gemma Chavarria-Miró1

  • 1Enteric Virus Laboratory, Department of Genetics, Microbiology and Statistics, School of Biology, and Institute of Nutrition and Food Safety, University of Barcelona, Barcelona, Spain.

Communications Biology
|June 12, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Hepatitis A virus (HAV) uses exosomes for egress from liver cells. A specific VP2 mutation enhances basolateral release via the syndecan-syntenin-ALIX pathway, a mechanism absent in human and chimpanzee HAV strains.

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.4K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Related Experiment Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.4K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Hepatitis A virus (HAV) exits infected liver cells (hepatocytes) within exosomes.
  • The precise mechanisms governing HAV exosome release from polarized hepatocytes remain incompletely understood.

Purpose of the Study:

  • To investigate the pathways involved in exosome-mediated HAV (eHAV) biogenesis and release.
  • To elucidate the role of the syndecan-syntenin-ALIX pathway in eHAV egress.

Main Methods:

  • Analysis of ALIX domain interactions with immature HAV capsids (VP1 and VP2).
  • Site-directed mutagenesis of VP2 (Serine-to-Glycine at position 134).
  • Assessment of eHAV egress pathways and RAB35 involvement.

Main Results:

  • The syndecan-syntenin-ALIX pathway, in addition to the ESCRT pathway, is implicated in eHAV biogenesis.
  • A conserved Serine-to-Glycine mutation at VP2 position 134 facilitates ALIX interaction and enhances basolateral eHAV egress, primarily via RAB35.
  • This specific VP2 mutation is absent in human and chimpanzee HAV strains.

Conclusions:

  • The syndecan-syntenin-ALIX pathway represents an alternative route for eHAV release.
  • Inefficient basolateral egress in apes may be an evolutionary strategy to evade host antiviral responses.